We are live on ! Find out more
EA

Emerald Advisers Portfolio holdings

AUM $4.25B
1-Year Est. Return 141.71%
This Fund
S&P 500
This Quarter Est. Return
+50.94%
1 Year Est. Return
+141.71%
3 Year Est. Return
+486.97%
5 Year Est. Return
+675.33%
10 Year Est. Return
+5,134.3%
AUM
$4.25B
AUM Growth
+$1.09B
Cap. Flow
-$109M
Cap. Flow %
-2.57%
Top 10 Hldgs %
17.4%
Holding
276
New
28
Increased
80
Reduced
84
Closed
39

Top Buys

Rank Stock Value
1
LGN
Legence Corp
LGN
+$53.3M
2
SXT icon
Sensient Technologies
SXT
+$43.9M
3
IDCC icon
InterDigital
IDCC
+$35.5M
4
ACLS icon
Axcelis
ACLS
+$34.7M
5
TEX icon
Terex
TEX
+$34.1M

Sector Composition

Rank Sector Weight
1 Technology 27.23%
2 Industrials 24.1%
3 Healthcare 21.93%
4 Financials 9.1%
5 Consumer Discretionary 9.02%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
TVTX icon
1
Travere Therapeutics
TVTX
$6.27B
$90.9M 2.14%
1,600,886
+43,690
+3% +$1.94M
CDNL
2
Cardinal Infrastructure Group
CDNL
$722M
$79.9M 1.88%
847,969
+269,369
+47% +$15.5M
MRCY icon
3
Mercury Systems
MRCY
$5.09B
$78.1M 1.84%
638,682
+43,368
+7% +$4.13M
AIR icon
4
AAR Corp
AIR
$5.06B
$74.6M 1.76%
521,919
+76,226
+17% +$9M
VSEC icon
5
VSE Corp
VSEC
$5.69B
$73.8M 1.74%
323,152
+8,363
+3% +$1.61M
KLIC icon
6
Kulicke & Soffa
KLIC
$4.12B
$73.8M 1.74%
551,535
-17,461
-3% -$1.71M
AGX icon
7
Argan
AGX
$5.77B
$71.3M 1.68%
89,296
-5,976
-6% -$3.98M
CECO icon
8
Ceco Environmental
CECO
$4.35B
$66.9M 1.57%
736,784
+213,767
+41% +$16.9M
CORT icon
9
Corcept Therapeutics
CORT
$12.2B
$65.1M 1.53%
748,325
+542,767
+264% +$32.8M
LIVN icon
10
LivaNova
LIVN
$4.47B
$64.7M 1.52%
787,101
+116,894
+17% +$8.27M
SMTC icon
11
Semtech
SMTC
$12.6B
$63.6M 1.5%
393,030
-63,988
-14% -$8.36M
IDCC icon
12
InterDigital
IDCC
$8.67B
$63.3M 1.49%
223,517
+119,452
+115% +$35.5M
ESE icon
13
ESCO Technologies
ESE
$7.1B
$62.9M 1.48%
179,798
+17,145
+11% +$5.36M
ACLS icon
14
Axcelis
ACLS
$3.41B
$62.6M 1.47%
330,469
+234,231
+243% +$34.7M
PDFS icon
15
PDF Solutions
PDFS
$1.84B
$62.6M 1.47%
884,294
+23,475
+3% +$1.16M
PLXS icon
16
Plexus
PLXS
$6.45B
$62.5M 1.47%
207,712
+41,180
+25% +$10.7M
COHU icon
17
Cohu
COHU
$2.18B
$62.4M 1.47%
843,627
+63,528
+8% +$3.18M
COGT icon
18
Cogent Biosciences
COGT
$6.06B
$62M 1.46%
1,603,319
+15,187
+1% +$531K
ALGT icon
19
Allegiant Air
ALGT
$2.07B
$55.9M 1.32%
475,112
+137,079
+41% +$11.9M
LGN
20
Legence Corp
LGN
$4.05B
$55.7M 1.31%
+653,788
New +$53.3M
MIRM icon
21
Mirum Pharmaceuticals
MIRM
$6.14B
$54.8M 1.29%
468,295
+71,032
+18% +$7.13M
GH icon
22
Guardant Health
GH
$21.6B
$54.6M 1.29%
364,022
-477,895
-57% -$52M
MOD icon
23
Modine Manufacturing
MOD
$9.91B
$54.1M 1.27%
202,754
-175,364
-46% -$46.2M
AX icon
24
Axos Financial
AX
$5.51B
$52.2M 1.23%
536,162
+39,930
+8% +$3.6M
SEI
25
Solaris Energy Infrastructure
SEI
$3.5B
$51.5M 1.21%
640,616
+45,929
+8% +$3.28M

Similar funds

Emerald Advisers's Q2 2026 Portfolio in Review

As of Q2 2026, Emerald Advisers held 276 positions worth $4.25B, up 34% from $3.16B the previous quarter. Its ten largest holdings account for 17% of the portfolio.

Emerald Advisers's Q2 2026 filing shows 28 new, 80 increased, 84 reduced and 39 closed positions. Its largest new stake was Legence Corp: 653,788 shares worth $55.7M. The largest sale was Bloom Energy, an estimated $137M.

By sector, the portfolio is most concentrated in Technology at 27% of assets, up from 26% a quarter earlier, followed by Industrials and Healthcare.

  • Emerald Advisers's largest Q2 2026 buy was Legence Corp: 653,788 shares worth $55.7M.
  • Emerald Advisers added most to InterDigital in Q2 2026, an estimated $35.5M increase.
  • Emerald Advisers's biggest Q2 2026 reduction was Bloom Energy, cutting an estimated $137M.
  • Emerald Advisers fully exited BridgeBio Pharma in Q2 2026, selling an estimated $38.3M.
  • Emerald Advisers's ten largest holdings make up 17% of its $4.25B portfolio in Q2 2026.
  • Emerald Advisers opened 28 new positions and closed 39 in Q2 2026.
  • Emerald Advisers's portfolio value rose 34% quarter-over-quarter to $4.25B.

Based on Emerald Advisers's 13F filing for Q2 2026, filed 5 Aug 2026.